Roger Song
Stock Analyst at Jefferies
(0)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VERV Verve Therapeutics | Downgrades: Hold | 28 11 | 11.25 | -2.22% | 1 | Jun 18, 2025 | |
CVAC CureVac | Downgrades: Hold | 7 5 | 5.45 | -8.26% | 1 | Jun 13, 2025 | |
KNSA Kiniksa Pharmaceutic... | Maintains: Strong Buy | 40 45 | 27.88 | 61.41% | 2 | Apr 29, 2025 | |
NKTR Nektar Therapeutics | Upgrades: Buy | 15 30 | 24.8 | 20.97% | 8 | Apr 11, 2025 | |
AKBA Akebia Therapeutics | Initiates Coverage On: Buy | 6 | 3.58 | 67.6% | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 7 | 3.15 | 122.22% | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 245 | 143 | 71.33% | 1 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 26 | 6.95 | 274.1% | 1 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 48 2 | 1.36 | 47.06% | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 42 7 | 4.28 | 63.55% | 2 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 16 19 | 9.55 | 98.95% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 32 28 | 5.86 | 377.82% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 2 7 | 1.44 | 386.11% | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 89 | 54.75 | 62.56% | 1 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 31 25 | 6.81 | 267.11% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 41 | 12.73 | 222.07% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 10.03 | 248.95% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | 5.2 | 73.08% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 108 129 | 33.25 | 287.97% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 3 8 | 2.5 | 220% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 97 | 80.48 | 20.53% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 41 72 | 16.42 | 338.49% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 110 | 28.14 | 290.9% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 31 2 | 2.65 | -24.53% | 2 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 35 | 4.79 | 630.69% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | 0.78 | 1053.85% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 675 | 2.05 | 32826.83% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 3.95 | 102.53% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 300 400 | 15.71 | 2446.15% | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | n/a | n/a | 1 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 315 | n/a | n/a | 1 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 21 | 0.76 | 2663.16% | 1 | Sep 2, 2020 |